Medtronic issues recall for MiniMed insulin pumps
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Medtronic Plc announced a voluntary recall Friday of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.
Medtronic issues recall for MiniMed insulin pumps over battery issues
Medtronic (MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. Read more here.
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
The original notification and the updated notification are available on the Medtronic Diabetes website. About the Diabetes Business at Medtronic (www.medtronicdiabetes.com) Medtronic is ...
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages.
Medtronic recalls select Minimed insulin delivery systems
Medtronic plc reported a voluntary recall of certain insulin pumps after customers said a single drop, bump, or physical impact could shorten their battery life.
Medtronic Recalls MiniMed Insulin Pumps Over Battery Issues -- Update
The Dublin-based medical-device maker said Friday that customers of its MiniMed 600 series or 700 series insulin pumps have reported shortened battery life in pumps that have been dropped or experienced some kind of physical impact that damaged internal components.
Medtronic Recalls MiniMed 600/700 Series Insulin Pumps For Shortened Battery Life
Medtronic plc, an Irish healthcare technology company, is recalling its MiniMed 600 series or 700 series insulin pumps citing
Medtronic shares dip after FDA tags insulin pump recall as Class I
Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.
Hosted on MSN1d
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic plc (NYSE: MDT ... accelerate in Cardiac Ablation Solutions and Neuromodulation with continued strength in Diabetes, Spine and Structural Heart products. The company provided in-line ...
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Discover why Medtronic is a top Dividend Aristocrat with strong financial performance and potential for 12% annual returns ...
News Medical28d
Retrograde Cannulae from Medtronic
Medtronic Retrograde Cannulae are offered in many different configurations of cuff, tip, stylet and handle design as well as choices of silicone or PVC body construction. Our product breadth ...
Yahoo Finance20d
Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks
This growth is bolstered by Medtronic's diversified product pipeline, including innovations in diabetes management, pulse field ablation, and robotics. The company's strong market position is ...
Benzinga.com28d
How Much Would It Take To Earn $100 A Month From Medtronic Stock?
and Diabetes. "Overall revenue outperformance flowed through to the bottom line, with adjusted EPS ahead of expectations," said Gary Corona, Medtronic's interim chief financial officer.
Medtronic Buy Rating Affirmed: Sustained Growth and Strong Pipeline Drive Positive Outlook
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Zacks.com on MSN5d
Reasons to Retain Medtronic Stock in Your Portfolio Now
Medtronic plc’s MDT growth is backed by remarkable progress within the Neurosurgery Portfolio. The company’s continuous ...